Disease activity guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis: a prospective, randomized, open-label, multicentric study

BACKGROUND: The aim of this study was to evaluate disease-activity-guided stepwise tapering or discontinuation of rhTNFR:Fc, an etanercept biosimilar, in patients with ankylosing spondylitis (AS) in a prospective, randomized, open-label, multicentric study. METHODS: Active AS patients with AS diseas...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ting, Zhu, Jianing, He, Dongyi, Chen, Xiaowei, Wang, Hongzhi, Zhang, Ying, Xue, Qin, Liu, Weili, Xiang, Guangbo, Li, Yasong, Yu, Zhongming, Wu, Huaxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268122/
https://www.ncbi.nlm.nih.gov/pubmed/32536984
http://dx.doi.org/10.1177/1759720X20929441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268122/
https://www.ncbi.nlm.nih.gov/pubmed/32536984
http://dx.doi.org/10.1177/1759720X20929441

Ejemplares similares